Literature DB >> 12548357

Magnetic resonance relaxometry in Parkinson's disease.

F Mondino1, P Filippi, U Magliola, S Duca.   

Abstract

A central role of iron in the pathogenesis of idiopathic Parkinson's disease (PD), due to its increase in substantia nigra pars compacta dopaminergic neurons and its capacity to enhance production of toxin reactive oxygen radicals, has been discussed for many years. Nuclear magnetic resonance (NMR) relaxation is considered an objective and noninvasive method of measuring regional iron concentrations. By means of this technique we investigated both controls and PD patients.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12548357     DOI： 10.1007/s100720200083

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  7 in total

Review 1.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

Review 2.  Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms.

Authors:  Daniela Berg
Journal:  Neurochem Res       Date:  2007-04-28       Impact factor: 3.996

3.  Reproducible detection of nigral iron deposition in 2 Parkinson's disease cohorts.

Authors:  Jason Langley; Naying He; Daniel E Huddleston; Shengdi Chen; Fuhua Yan; Bruce Crosson; Stewart Factor; Xiaoping Hu
Journal:  Mov Disord       Date:  2018-12-30       Impact factor: 10.338

Review 4.  Rapid MR relaxometry using deep learning: An overview of current techniques and emerging trends.

Authors:  Li Feng; Dan Ma; Fang Liu
Journal:  NMR Biomed       Date:  2020-10-15       Impact factor: 4.478

5.  A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits.

Authors:  Federica Maccarinelli; Antonella Pagani; Anna Cozzi; Franca Codazzi; Giuseppina Di Giacomo; Sara Capoccia; Stefania Rapino; Dario Finazzi; Letterio Salvatore Politi; Francesca Cirulli; Marco Giorgio; Ottavio Cremona; Fabio Grohovaz; Sonia Levi
Journal:  Neurobiol Dis       Date:  2014-11-04       Impact factor: 5.996

6.  Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease.

Authors:  Naying He; Jason Langley; Daniel E Huddleston; Shengdi Chen; Pei Huang; Huawei Ling; Fuhua Yan; Xiaoping Hu
Journal:  Neuroimage Clin       Date:  2020-08-20       Impact factor: 4.881

Review 7.  Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.

Authors:  Daniela Berg; Helmine Hochstrasser; Katherine J Schweitzer; Olaf Riess
Journal:  Neurotox Res       Date:  2006-01       Impact factor: 3.978
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.